HeartFlowHTFL -3.57%12 Earnings Yield (Joel Greenblatt) % is -5.19% as of Mar. 2026. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 688 Healthcare Providers & Services companies, HeartFlow ranks worse than 78.34% on this metric.
HeartFlow's Enterprise Value for the quarter that ended in Mar. 2026 was $1,963.0 Mil.
HeartFlow's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-101.8 Mil. HeartFlow's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was -5.19%.
The historical rank and industry rank for HeartFlow's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
HTFL'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -10.18 Med: -4.5 Max: -2.54
Current: -4.69
During the past 3 years, the highest Earnings Yield (Joel Greenblatt) of HeartFlow was -2.54%. The lowest was -10.18%. And the median was -4.50%.
HTFL's Earnings Yield (Joel Greenblatt) % is ranked worse than 78.34% of 688
companies
in the Healthcare Providers & Services industry
Industry Median: 3.225
vs HTFL: -4.69
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. HeartFlow's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
HeartFlow Earnings Yield (Joel Greenblatt) % Related Terms
HeartFlow Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for HeartFlow's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, HeartFlow's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartFlow Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HeartFlow's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where HeartFlow's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
HeartFlows Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
HeartFlow's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-101.8 Mil.
What does a Earnings Yield (Joel Greenblatt) % of -5.19% mean?
HeartFlow (HTFL) has a Earnings Yield (Joel Greenblatt) % of -5.19% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on HeartFlow and its competitors. According to the industry distribution chart, HeartFlow ranks #539 out of 688 companies in the Healthcare Providers & Services industry, placing it in the top 78.3%.
Is HeartFlow's Earnings Yield (Joel Greenblatt) % too high?
HeartFlow's current Earnings Yield (Joel Greenblatt) % is -5.19%. Based on the distribution chart, HeartFlow ranks #539 out of 688 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Earnings Yield (Joel Greenblatt) % compare to PRVA and WAY?
According to the Healthcare Providers & Services industry distribution chart, HeartFlow ranks #539 out of 688 companies for Earnings Yield (Joel Greenblatt) %. This places HeartFlow in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.23, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on HeartFlow and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartFlow's current Earnings Yield (Joel Greenblatt) % is -5.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Earnings Yield (Joel Greenblatt) % of -5.19%. The current Earnings Yield (Joel Greenblatt) % is -5.19%. HeartFlow's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For HeartFlow (HTFL), the current Earnings Yield (Joel Greenblatt) % is -5.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score
Get the complete analysis for HTFL
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HTFL has been successfully added to your 
